A practical reference on GLP-1 receptor: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-03-05 and is reviewed periodically as new material appears.
Semaglutide is a synthetic peptide that acts as an agonist at the glucagon-like peptide-1 receptor. It is a structural analogue of human GLP-1(7-37), modified to resist enzymatic degradation by dipeptidyl peptidase-4. The peptide backbone contains alpha-aminoisobutyric acid at position 8, a substitution that stabilises the helix and slows cleavage. A fatty diacid side chain attached through a linker at lysine 34 promotes binding to serum albumin, which extends the circulating half-life. These two modifications together allow less frequent administration than native GLP-1 requires.
Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | Parent peptide; salt forms also reported |
| Molecular mass | about 4113.6 Da | Average mass of the free peptide |
| Peptide length | 31 amino acids | Backbone related to GLP-1(7-37) |
| Key substitution | Aib at position 8 | Blocks DPP-4 cleavage |
| Albumin binding | Via C-18 diacid side chain | Prolongs circulation time |
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Protection: an anatomical barrier from pathogens and damage between the internal and external environment in bodily defence; Langerhans cells in the skin are part of the adaptive immune system. Perspiration contains lysozyme that break the bonds within the cell walls of bacteria. Sensation: contains a variety of nerve endings that react to heat and cold, touch, pressure, vibration, and tissue injury; see somatosensory system and haptics. Heat regulation: the skin contains a blood supply far greater than its requirements, which allows precise control of energy loss by radiation, convection and conduction. Dilated blood vessels increase perfusion and heat loss, while constricted vessels greatly reduce cutaneous blood flow and conserve heat. Control of evaporation: the skin provides a relatively dry and semi-impermeable barrier to fluid loss. Loss of this function contributes to the massive fluid loss in burns. Aesthetics and communication: others see skin and can assess mood, physical state and attractiveness. Storage and synthesis: acts as a storage centre for lipids and water, as well as a means of synthesis of vitamin D by action of UV on certain parts of the skin. Excretion: sweat contains urea, however its concentration is 1/130th that of urine, hence excretion by sweating is at most a secondary function to temperature regulation. Absorption: the cells comprising the outermost 0.25–0.40 mm of the skin are "almost exclusively supplied by external oxygen", although the "contribution to total respiration is negligible".
Mackay snakehandler Ram Chandra traveled around Queensland and northern NSW, in part funded by the sugar industry. Sugarcane growers began to have trouble finding workers due to fears around the taipan. To counteract fears, the Queensland Cane Growers' Council produced an article in 1956 to calm panic, and Eric Worrell and David Fleay pointed out the snake's inherent shyness. In 1949 and 1950, 19-year-old snake handler Kevin Budden visited north Queensland to catch a taipan in a quest to develop antivenom. On 27 July 1950, he caught a specimen sunning itself in a rubbish dump on the outskirts of Cairns by putting his foot on it, grasping it by the neck with his left hand and letting it coil around his arm. He then walked to a main road and hailed a passing truck to take him to the house of local naturalist S.E. Stephens. Once there, the taipan escaped his grasp as he attempted to adjust his hold and bit his hand. Despite this, he secured the snake before going to hospital. He became paralysed later that day and succumbed early the following afternoon despite ventilation and large doses of tiger snake antivenom. Before he died, Budden requested the snake be sent to the Commonwealth Serum Laboratories, which in turn forwarded it to Fleay for milking. Fleay did so successfully, but found wrestling with the surprisingly strong and muscular subject to be difficult. They procured 78 mg of whitish venom, which led to the development of taipan antivenom. The snake itself became a minor celebrity, discussed in many newspapers at the time.
Singapore's diversity of cuisine is touted as a reason to visit the country, due to its combination of convenience, variety, quality, and price. Local food items generally relate to a particular ethnicity – Chinese, Malay and Indian; but the diversity of cuisine has increased further by the hybridisation of different styles (e.g., the Peranakan cuisine, a mix of Chinese and Malay cuisine). In hawker centres, cultural diffusion is exemplified by traditionally Malay hawker stalls also selling Tamil food. Hainanese chicken rice, based on the Hainanese dish Wenchang chicken, is considered Singapore's national dish. The city-state has a burgeoning food scene ranging from hawker centres (open-air), food courts (air-conditioned), coffee shops (open-air with up to a dozen hawker stalls), cafes, fast food, simple kitchens, casual, celebrity and high-end restaurants. Cloud kitchens and food delivery are also on the rise, with 70% of residents ordering from delivery apps at least once a month. Many international celebrity chef restaurants are located within the integrated resorts. Religious dietary strictures exist (Muslims do not eat pork and Hindus do not eat beef), and there is also a significant group of vegetarians. The Singapore Food Festival which celebrates Singapore's cuisine is held annually in July. Prior to the 1980s, street food was sold mainly by immigrants from China, India, and Malaysia to other immigrants seeking a familiar taste. In Singapore, street food has long been associated with hawker centres with communal seating areas.
The cause is unclear in sarcoidosis, especially since clubbing is rare and happens in an advanced fibrotic stage. The exact pathogenesis in hemiplegia is unknown aside from alterations in blood flow due to autonomic nervous system instability. The vagus nerve may play a role in cases linked to inflammatory bowel disease and/or lung cancer. The exact cause of sporadic clubbing is unknown.
Sources: en.wikipedia.org
The majority of the population of Jammu and Kashmir is Muslim and a large minority is Hindu. Most Muslims in Jammu and Kashmir belong to the Sunni sect of Islam, especially the Gurjars, Bakarwals, Sayids, Pathans, Sheikhs, Mughals, Paharis, and Doms. As per the 2011 census of India, about 68.3% of people in Jammu and Kashmir were Muslims. Hindu made up around 28.4% of the population. Other small religious groups included Sikhs at 1.9%, Buddhists at 0.9%, and Christians at 0.3%. The population of the Kashmir Division is predominantly Muslim (96.41%) with small Hindu (2.45%) and Sikh (0.81%) communities. Shias are mostly concentrated in the Budgam district, where they form about 30–40% of the population. Among the Kashmiri Hindus, the Pandits are a significant group. The Jammu Division is predominantly Hindu (67.5%) with a significant Muslim population (30%). The Muslims form a majority in the Rajouri (63%), Poonch (90%), Doda (54%), Kishtwar (58%) and Ramban (71%) districts of Jammu, while the Hindus form a majority in Kathua (88%), Samba (86%), Jammu (84%) and Udhampur (88%) districts. Reasi district has an almost equal number of Hindus and Muslims. Most Dogras in the region are Hindus and belong to various Hindu castes. Paharis include both Hindu and Muslims. The Gurjars and Bakarwals are predominantly Sunni Muslims.
== Production of biomass == Microbial cells or biomass is sometimes the intended product of fermentation. Examples include single cell protein, bakers yeast, lactobacillus, E. coli, and others. In the case of single-cell protein, algae is grown in large open ponds which allow photosynthesis to occur. If the biomass is to be used for inoculation of other fermentations, care must be taken to prevent mutations from occurring.
=== Shareholders === Silicon Valley Bank's holding company, SVB Financial Group, was a component of the S&P 500. At the time of the collapse, its largest shareholders included The Vanguard Group, BlackRock, and State Street Corporation, which owned the stock in large exchange traded funds that track the performance of S&P 500. The South Korean National Pension Service owned 100,000 shares in SVB's holding company, SVB Financial Group. CalPERS (California state pension fund) held about $67 million in bonds to the bank, or less than two percent of one percent of total investments, as of June 2022. On March 13, shares of similar regional banks, including First Republic Bank, Western Alliance Bancorporation, and PacWest Bancorp plummeted.
Sources: en.wikipedia.org
It belongs to the incretin mimetic class and acts as a long-acting glucagon-like peptide-1 receptor agonist. The class includes several peptides with different half-lives and routes of administration.
The side chain enables reversible binding to albumin in the bloodstream, which protects the peptide from rapid renal clearance. This extends the interval between administrations compared with unmodified GLP-1.
No. It shares much of the native sequence but carries substitutions and an added side chain. These changes increase stability against enzymatic breakdown.
It is a synthetic peptide of 31 amino acids, built to resemble the natural incretin hormone GLP-1. Because of its size and composition it is handled analytically like other therapeutic peptides, using chromatographic and mass spectrometric methods rather than the techniques typical of small organic drugs.